254 related articles for article (PubMed ID: 22703658)
1. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin.
Liu L; Zhang C; Hu Y; Peng B
J Endod; 2012 Jul; 38(7):943-7. PubMed ID: 22703658
[TBL] [Abstract][Full Text] [Related]
2. The effect of estrogen deficiency on receptor activator of nuclear factor kappa B ligand and osteoprotegerin synthesis in periapical lesions induced in rats.
Zhang X; Peng B; Fan M; Bian Z; Chen Z
J Endod; 2007 Sep; 33(9):1053-6. PubMed ID: 17931931
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and antiresorptive functions of melatonin on experimentally induced periapical lesions.
Sarıtekin E; Üreyen Kaya B; Aşcı H; Özmen Ö
Int Endod J; 2019 Oct; 52(10):1466-1478. PubMed ID: 31063611
[TBL] [Abstract][Full Text] [Related]
4. Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions.
Xiong H; Wei L; Hu Y; Zhang C; Peng B
Int Endod J; 2010 Jun; 43(6):485-91. PubMed ID: 20536576
[TBL] [Abstract][Full Text] [Related]
5. The expression of macrophage migration inhibitory factor is correlated with receptor activator of nuclear factor kappa B ligand in induced rat periapical lesions.
Liu L; Peng B
J Endod; 2013 Aug; 39(8):984-9. PubMed ID: 23880264
[TBL] [Abstract][Full Text] [Related]
6. Local osteoprotegerin gene transfer to periodontal tissue inhibits lipopolysaccharide-induced alveolar bone resorption.
Chen R; Kanzaki H; Chiba M; Nishimura M; Kanzaki R; Igarashi K
J Periodontal Res; 2008 Apr; 43(2):237-45. PubMed ID: 18086145
[TBL] [Abstract][Full Text] [Related]
7. Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions.
Chuang FH; Tsai CC; Chen JH; Chen KK; Chen YK; Lin YC
J Oral Pathol Med; 2012 Feb; 41(2):186-93. PubMed ID: 21793936
[TBL] [Abstract][Full Text] [Related]
8. Boric acid inhibits alveolar bone loss in rats by affecting RANKL and osteoprotegerin expression.
Sağlam M; Hatipoğlu M; Köseoğlu S; Esen HH; Kelebek S
J Periodontal Res; 2014 Aug; 49(4):472-9. PubMed ID: 24033134
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
[TBL] [Abstract][Full Text] [Related]
10. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
11. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease.
Belibasakis GN; Rechenberg DK; Zehnder M
Int Endod J; 2013 Feb; 46(2):99-111. PubMed ID: 22900632
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number.
da Silva RA; Ferreira PD; De Rossi A; Nelson-Filho P; Silva LA
J Endod; 2012 Jun; 38(6):803-13. PubMed ID: 22595116
[TBL] [Abstract][Full Text] [Related]
13. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
Menezes R; Bramante CM; da Silva Paiva KB; Letra A; Carneiro E; Fernando Zambuzzi W; Granjeiro JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions.
Kawashima N; Suzuki N; Yang G; Ohi C; Okuhara S; Nakano-Kawanishi H; Suda H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):707-11. PubMed ID: 17336108
[TBL] [Abstract][Full Text] [Related]
16. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of bone remodelling during mandibular distraction osteogenesis in rats].
Zhu WQ; Wang X; Wang XX; Wang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Dec; 42(12):729-32. PubMed ID: 18476557
[TBL] [Abstract][Full Text] [Related]
18. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis.
Silva JA; Lopes Ferrucci D; Peroni LA; de Paula Ishi E; Rossa-Junior C; Carvalho HF; Stach-Machado DR
Cells Tissues Organs; 2012; 196(2):137-50. PubMed ID: 22301390
[TBL] [Abstract][Full Text] [Related]
19. Cimetidine reduces alveolar bone loss in induced periodontitis in rat molars.
Longhini R; Aparecida de Oliveira P; Sasso-Cerri E; Cerri PS
J Periodontol; 2014 Aug; 85(8):1115-25. PubMed ID: 24283656
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats.
Liu S; Cheng Y; Xu W; Bian Z
J Endod; 2010 Apr; 36(4):658-63. PubMed ID: 20307740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
